RPG Life Sciences Limited has informed the Exchange that Board of Directors at its meeting held on April 28, 2025, recommended Final Dividend of Equity share (250% on the face value of Rs 8 each) and additionally a special dividend of Rs. 4 (Rupees Four only) per equity share (50% on the face value of Rs. 8 each) on account of significant exceptional profit on assignment of land for the financial year 2024-25, subject to the approval of shareholders at the ensuing Annual General Meeting.
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
RPG Life Sciences' Board of Directors, at its meeting on April 28, 2025, recommended a Final Dividend of 250% on the face value of Rs 8 per share, which works out to Rs 20 per equity share. In addition, the Board declared a special dividend of Rs 4 per share (50% on face value), linked to an exceptional profit earned from the assignment of land during FY 2024-25. Together, shareholders stand to receive Rs 24 per share as total dividend for the year. Both dividends are subject to approval from shareholders at the upcoming Annual General Meeting. The special dividend is a one-time payout driven by a non-recurring land deal gain.
Short-term positive for shareholders due to the combined Rs 24 per share payout, but the special dividend reflects a one-time land gain and is not expected to recur. Investors should view the base final dividend as the sustainable component for future income expectations.